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D

espite the broad advances made in cancer research and interventions in the last quarter of a century, inequality still persists as we
confront challenges arising from the unequal burden of cancer
among Americans. Some racial and ethnic minorities, people with low
incomes, those in rural areas, and other medically underserved populations suffer disproportionately from cancer. We know, for example, that African Americans are about 34% more likely to die of cancer
than whites and more than two times more likely to die of cancer than
Asian/Pacific Islanders, American Indians, or Hispanics.
Disparities also exist among the major racial and ethnic groups in
health-risk behaviors, such as cigarette smoking, and use of clinical
preventive services, such as screening for breast, cervical, and colorectal cancers. The Centers for Disease Control and Prevention’s
(CDC) Behavioral Risk Factor Surveillance System (BRFSS), which was
developed in cooperation with federal, state, and private-sector partners, has equipped us with knowledge of variations in health risks as
well as information about differences among racial and ethnic groups
for health-risk behaviors. Results from the 1997 BRFSS Survey showed
that American Indians/Alaska Natives were most likely among all
groups to report cigarette smoking. Hispanic and American Indian/
Alaska Native women were less likely than women in other racial and
ethnic groups to use preventive services, such as Papanicolaou testing
and mammography. These statistics are disheartening and remind us
that much work remains to remove the disproportionate burden of
cancer among our nation’s diverse populations.
Achieving better cancer control within minority and underserved
populations in the United States is an important CDC goal. In its
commitment to reducing disparities in the nation’s cancer burden,
CDC focuses its cancer control resources on support for surveillance
systems that provide high quality cancer data for all Americans and
on the design and implementation of interventions that promote the
prevention and early detection of cancer, with emphasis on the underserved.

Cancer Surveillance
Surveillance activities are at the foundation of public health practice,
and they are the primary way we gain an understanding of cancer’s
effect on populations. Chief among CDC’s cancer surveillance systems is the National Program of Cancer Registries (NPCR), which was
established by Congress in 1992. Through the NPCR, CDC supports
complete, timely, and standardized reporting of cancer data—within
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FIGURE 1. Map from the Centers for Disease Control and Prevention showing the National Program of Cancer Registries funding for the year 2000. SEER Program:
Surveillance, Epidemiology, and End Results Program. Source: National Program of Cancer Registries, Division of Cancer Prevention and Control, National Center
for Chronic Disease Prevention and Health Promotion, July 1, 2000.
a state, between states, and between regions. CDC’s
NPCR will be an effective mechanism for monitoring
cancer trends and will be an invaluable data source for
identifying the burden of disease among racial and
ethnic minority populations. NPCR data also will be
helpful in directing cancer control efforts and research, developing and evaluating prevention and
control programs, and ensuring that health resources
are directed where they are most needed.
The NPCR complements the National Cancer Institute’s (NCI) Surveillance, Epidemiology, and End
Results (SEER) program. The SEER program gathers
in-depth cancer data on the population in five states
(Connecticut, Hawaii, Iowa, New Mexico, and Utah);
in the metropolitan areas of Atlanta, Detroit, Los Angeles, San Francisco-Oakland, San Jose-Monterey, and
Seattle-Puget Sound; and in selected populations of
American Indians in Arizona, Alaska Natives in Alaska,
and residents of 10 rural counties in Georgia, covering
about 14% of the U.S. population. NPCR supports
central cancer registries in 45 states, 3 territories, and
the District of Columbia; 45 of these areas are enhanc-

ing established registries, and 4 are developing and
implementing registries in areas where none existed
previously or where registries operated only in a limited capacity (Fig. 1). SEER-supported regional registries provide their data to the NPCR-supported state
central registry. The NPCR covers 96% of the U.S.
population.
NPCR-supported registries are expected to meet
CDC data standards as well as standards incorporated
for data quality and format as described by the North
American Association of Central Cancer Registries
(NAACCR). NAACCR, a collaborative organization for
North American cancer registries, governmental agencies, professional associations, and private groups interested in enhancing the quality and use of cancer
registry data, has established a certification process
for registries to recognize those that have complete,
high quality, and timely cancer incidence data.
As of spring 2000, 29 NPCR registries and all SEER
state and regional programs are independently certified by NAACCR (Table 1). This accomplishment illustrates the large improvement in cancer registration
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TABLE 1
North American Association of Central Cancer Registries: Certified
Cancer Registries in the United Statesa
National Program of Cancer Registries
Alaska
Arizona
California
Colorado
Delaware
District of Columbia
Florida
Idaho
Illinois
Kansas
Kentucky
Louisiana
Maryland
Massachusetts
Minnesota
Montana
Nebraska
New Hampshire
New Jersey
New York
North Carolina
Oregon
Pennsylvania
Rhode Island
South Carolina
Washington
West Virginia
Wisconsin
Wyoming
Surveillance, Epidemiology, and End Results Program
State registries
Connecticut
Hawaii
Iowa
New Mexico
Utah
Regional registries (metropolitan areas)
Atlanta
Detroit
Los Angeles
San Francisco-Oakland
San Jose-Monterey
Seattle-Puget Sound
a

Certified to meet the North American Association of Central Cancer Registries standards for completeness, timeliness, and quality.

that has occurred since the early 1990s, when 10 states
had no registry. Many of the 40 states that did have
operating registries lacked the financial and staff support needed for gathering complete, timely, and accurate data on their population and ensuring that the
data collected met minimum standards of quality. The
United States now has much better data on many
more Americans as well as data that could be used to
analyze regional differences in cancer rates, including
data on minority groups.
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The primary reason for collecting, analyzing, and
disseminating data, of course, is to use the information to advance cancer prevention and control. For
example, one special study is using cancer registry
data to analyze differences between African Americans and whites in colorectal cancer incidence and
stage of disease at diagnosis. This analysis, using
1991–1995 data from 21 population-based cancer registries, was conducted by the Cancer Incidence Reporting Committee of NAACCR and included more
than 216,000 cases of colorectal cancer.
Preliminary results of this study showed that African Americans were less likely to be diagnosed with
localized colorectal cancer, and African-American
men had the highest rates. African Americans also
were more likely than whites to be diagnosed with
disease involving the proximal colon. This information
may be important when determining which colorectal
cancer screening methods may be most suitable for
African Americans as well as for designing appropriate
messages for health communications.
Additional examples of using cancer surveillance
activities to identify the unequal cancer burden are
evident in studies conducted in Illinois and California.
The Illinois State Cancer Registry studied Hispanic
identification procedures and subsequently established a policy to foster more accurate documentation
of Hispanic ethnicity among persons reported with
cancer. In California, the Cancer Registry routinely
reports cancer rates for Hispanics and for Asian and
Pacific Islanders, including Chinese, Filipino, Japanese, Korean, and selected Asian subgroups. A recent
report from a California Cancer Registry study suggested that the state’s tobacco control program may
have helped decrease rates for lung cancer among
racial and ethnic minority women.
During the past year, CDC has begun implementing the NPCR-Cancer Surveillance System (NPCRCSS), which is a major step forward in addressing the
need for a comprehensive cancer data base. When it is
fully operational, the NPCR-CSS will receive, assess,
enhance, aggregate, and disseminate data from NPCR
programs. This system will provide public-use data
files of cancer incidence; more accurate and stable
estimates of cancer incidence for special population
groups, including racial and ethnic minorities, medically underserved groups, and other subpopulations;
more accurate analysis of the cancer burden on a
regional and national level; a basis for special studies,
including studies involving rare cancers, cancers
among children, and cancers among racial and ethnic
minority populations; and valuable feedback to registries for improving data quality and use. In addition,
the NPCR-CSS will provide information to aid in the
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task of assessing the unequal quality of cancer care in
this country.
The first official “call for data” for the NPCRCancer Surveillance System is scheduled for January
2001. Once a registry’s data meet quality standards,
the data can be included in special research data bases
that can be made available to public health practitioners and cancer researchers.
The need for a national data base has been recognized by various organizations involved in cancer
control, including the Institute of Medicine (IOM).
After a National Cancer Policy Board workshop in
October 1999 that was designed to address the need
for enhanced data systems to improve the quality of
cancer care, the IOM recommended broader support
for U.S. registry operations. For example, expansion of
registry activities could support inclusion of follow-up
data for survival analyses; at present, the NPCR supports data collection primarily for cancer incidence
reporting. Major additional resources would be required to provide the extra capacity for assessing
treatment and survival after cancer diagnoses. However, the infrastructure is now there. When it is fully
implemented and functioning, the NPCR will provide
the most comprehensive data to show cancer incidence and mortality among all Americans.

Tobacco Control
In addressing tobacco-related cancers, the CDC’s tobacco control efforts include research and surveillance activities as well as support for state health programs. In 1998, CDC issued the first Surgeon General’s
Report on tobacco and minorities. This report clearly
showed tobacco’s increasing grip on racial and ethnic
minorities. The report concluded that: 1) Cigarette
smoking is a major cause of disease and death among
the Hispanics, African Americans, American Indians/
Alaska Natives, Asian Americans, and Pacific Islanders
studied for this report; African Americans currently
bear the greatest tobacco-related disease burden. 2)
Tobacco use varies within and among racial and ethnic minority groups; among adults, American Indians/
Alaska Natives have the highest prevalence of tobacco
use; African-American and Southeast-Asian men also
have a high prevalence of smoking. Asian-American
and Hispanic women have the lowest prevalence. 3)
Among adolescents, the prevalence of cigarette smoking increased in the 1990s among African Americans
and Hispanics after several years of substantial decline. This increase is particularly striking among African-American youths, who had the greatest decline
in smoking rates during the 1970s and 1980s.
CDC now supports comprehensive programs for
preventing and controlling tobacco use in all 50 states,

the District of Columbia, and 8 U.S. territories. These
activities are targeted to reach multiple populations,
especially high risk groups such as young people, racial and ethnic minority groups, and persons with low
income. CDC provides extensive technical assistance
and training to support these programs. The agency
also supports tobacco-related symposia, such as the
one on “Issues in Research: Tobacco Use in Racial/
Ethnic Groups” that was conducted at the 2000 conference of the Society for Research on Nicotine and
Tobacco. In addition, CDC has provided scientific and
technical assistance for the National Youth Tobacco
Survey. This survey revealed that the prevalence of
current cigarette smoking among African-American
middle school students (9%) was similar to that
among white (9%) and Hispanic (11%) middle school
students, which may be an early indication that the
differences in smoking rates between African-American and white students may be disappearing.

Colorectal Cancer Control
Colorectal cancer is another area in which the excess
burden of cancer among minorities is evident. We
know, for example, that African Americans are more
likely than whites to be diagnosed with colorectal cancer at a more advanced stage and are more likely to die
of the disease. We also know that several effective
screening tests for colorectal cancer exist, but screening usage rates are low among all groups in the United
States.
In collaboration with the American Cancer Society, CDC supports the National Colorectal Cancer
Roundtable—a coalition of public, private, and voluntary organizations—to promote awareness and use of
colorectal cancer screening. Partners include professional organizations, medical societies, federal agencies, health departments, consumers, cancer survivors, managed care organizations, and the medical
communications media. In addition, CDC is supporting several colorectal cancer research activities that
focus on minority populations. For example, CDC is
working with the NCI to enhance recruitment of African-American men for participation in the 15-year
randomized, controlled trial of screening for prostate,
lung, colorectal, and ovarian cancers (PLCO). The focus of the colorectal screening in the PLCO trial is
flexible sigmoidoscopy. CDC also is collaborating with
Memorial Hospital of Rhode Island to identify sociocultural and psychological influences affecting Hispanics’ beliefs, attitudes, and practices associated with
cancer prevention, including colorectal cancer screening.
CDC, with support from the Health Care Financing Administration and the NCI, has launched a na-
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tional media campaign—“Screen for Life”---to promote screening for and early detection of colorectal
cancer. This campaign also highlights Medicare’s coverage for colorectal cancer screening. Public service
announcements have been developed specifically for
African-American audiences. CDC also is helping develop “Screen for Life” educational materials that are
targeted directly to Alaska Native populations. This
special project is designed to increase awareness of
colorectal cancer among Alaska Natives, increase
awareness of colorectal cancer screening tests, and
provide language for persons to use in discussing
colorectal cancer screening with their health care providers.

Early Detection of Breast and Cervical Cancer
Although effective screening tools for breast and cervical cancer are available, many women are not taking
advantage of early detection methods because of financial, educational, or cultural factors. Through the
National Breast and Cervical Cancer Early Detection
Program (NBCCEDP), CDC is increasing the awareness, availability, and use of screening for underserved
women. Racial and ethnic minority women and
women with low income are high priority populations.
Now in its 10th year, the NBCCEDP operates in all 50
states, the District of Columbia, 6 U.S. territories, and
12 American Indian/Alaska Native organizations, providing free or low-cost screening and diagnostic services for women. More than 2 million screening examinations have been provided since the program
started in 1991. A review of program data reveals that
almost half of the women screened by the NBCCEDP
have been from a racial or ethnic minority.
CDC has begun a research project that will identify and describe successful strategies and approaches
used by CDC-sponsored tribal organizations participating in the NBCCEDP. Results from this research
project will be useful for improving the delivery of
these important services to American Indian/Alaska
Native women. Five tribal organizations are participating in this qualitative research effort that uses a
case-study model. Focus groups will be conducted
with program providers as well as with women clients
in the program. This project has the potential to be an
outstanding example of participatory research. From
the earliest planning stages, the tribal program providers and managers have been involved. In addition,
two expert American Indian researchers have been an
integral part of the research team.
CDC also is coordinating and managing the Racial
and Ethnic Approaches to Community Health
(REACH) demonstration projects. REACH is part of the
U.S. Department of Health and Human Services’ re-
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sponse to the President’s Race Initiative and the
Healthy People Goals for 2010 to eliminate the disparities in health status experienced by racial and ethnic
minority populations. Through REACH, CDC is supporting community coalitions in 18 states; 6 of these
coalitions are being funded this year to address racial
and ethnic disparities in breast and cervical cancer.
REACH awards put funds into the hands of minority
health organizations to develop effective communityoriented strategies. Both public and private agencies
have expressed interest in supporting or participating
in the REACH 2010 Program. Evaluation of these
projects will be critically important in documenting
whether these strategies are successful in reducing
health disparities among racial and ethnic minority
populations.

Prostate Cancer Initiatives
Prostate cancer burden, which affects African-American men disproportionately, is another example of the
health disparities among America’s racial and ethnic
populations. At all ages, African-American men are
diagnosed with prostate cancer at later stages and die
of prostate cancer at higher rates than white men.
Screening tests can detect the disease at early stages,
but scientists are unsure whether early detection and
treatment actually reduce mortality from this disease.
Furthermore, the treatment procedures after the early
detection of prostate cancer can have serious consequences.
In the absence of expert consensus on the effectiveness of screening in reducing mortality from prostate cancer, public health agencies face a significant
challenge in determining how best to address this
major cause of cancer death. CDC’s current efforts
focus on building the science base for understanding
the best strategies for prostate cancer control. A case–
control study supported by CDC is under way to evaluate the effect of prostate cancer screening (prostate
specific antigen testing and digital rectal examination)
on prostate cancer mortality. To maximize the likelihood that study results will be useful for AfricanAmerican men as well as for white men, the study was
designed to over-sample African-American men for
the control group. To help CDC and the states design
better public health programs to control prostate cancer, CDC has funded state cancer registries to collect
and report better information regarding prostate cancer, especially with regard to disease stage of diagnosis, and racial and ethnic information.
CDC also is working with the Henry Ford Health
System in Detroit, the University of Alabama at Birmingham, and the NCI to increase the recruitment of
African-American men into the PLCO cancer screen-
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ing trials. The prostate cancer arm of these trials is designed to answer the critical question of whether screening for prostate cancer actually reduces death rates.
Lessons learned from the Detroit study about increasing
recruitment of African-American men are being applied
to the University of Alabama recruitment process.

CONCLUSIONS
CDC has learned many lessons about advancing cancer prevention and control. We have learned that providing effective interventions to the target populations
requires building a broad cancer control infrastructure, which takes time. We have learned that the success of a national cancer screening program, such as
the National Breast and Cervical Cancer Early Detection Program, depends on the integration and coordination of key components: research, quality assurance, public and professional education, health
communications, and surveillance and evaluation systems. We have learned about the challenges in reaching diverse populations. Outreach strategies for priority populations must be developed if we are to

improve their access to cancer screening services.
Health communication messages must be tailored to
be linguistically appropriate and culturally relevant to
reach different population groups.
Finally, we know that addressing the complex array of public health challenges in cancer prevention
and control requires a concerted effort by nonprofit
organizations, government agencies, and businesses—
groups that are willing to work together to address the
economic, behavioral, and systemic factors that affect
the use of cancer control services. Dynamic partnerships are absolutely critical to the success of cancer
prevention and control efforts. For example, CDC has
collaborated with more than 60 private, public, and
federal organizations in implementing the NBCCEDP.
Our collective efforts will continue to move us forward
toward eliminating the disproportionate cancer burden in America’s racial and ethnic communities.
Working together, we can eliminate the disparities;
working together, we can accomplish social justice in
the public health arena through effective cancer prevention and control for all Americans.

